BOSTON, Mass.--(BUSINESS WIRE)--OvaScience™, an innovative life science company dedicated to improving the treatment of infertility, today announced the appointment of Jeffrey D. Capello, executive vice president and chief financial officer of Boston Scientific (NYSE: BSX), to its board of directors.
